6.18 USD
↘ 0.23 (3.59%)AT CLOSE (03:59 PM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
6.20
↗ 0.02 (0.32%)
POST MARKET (AS OF 06:45 PM EDT)
Post Market
AS OF 06:45 PM EDT
6.20
↗ 0.02 (0.32%)
Market: CLOSED
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $6.18 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (122.9%) and a bearish Death Cross on the long-term moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 23, 2026.
Open?$6.38
High?$6.52
Low?$6.11
Prev. Close?$6.41
Volume?85.9K
Avg. Volume?146.5K
VWAP?$6.19
Rel. Volume?0.59x
Bid / Ask
Bid?$5.80 × 100
Ask?$6.28 × 100
Spread?$0.48
Midpoint?$6.04
Valuation & Ratios
Market Cap?187.0M
Shares Out?30.3M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.49
EPS?-$5.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
187.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.57Distress
Confidence?60%Moderate
Short InterestVery High
Short % of Float?15.39%High
Short Interest?1.9M
Days to Cover?12.6
Free Float12.1M
Avg Daily Volume146.8K
Settlement Date2026-09-30
Financial Health
Current Ratio?7.48Strong
Quick Ratio?7.48Strong
Cash Ratio?7.18Strong
Debt/Equity?-0.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.49CHEAP▾
S&P97
P/S?126.59HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.0CHEAP▾
S&P97
EV/Sales?62.44HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?122.9%STRONG▾
Peers50
S&P97
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-78612000
Enterprise Value?$92.2M
Fundamentals ratios updated end of day